Axinn Represents Berkshire Partners in the Antitrust Aspects of its Acquisition of Forcura and Medalogix
March 19, 2025
Axinn successfully represented Berkshire Partners in the antitrust aspects of the parallel acquisitions of two post-acute care software companies: Forcura, an intelligent workflow management company; and Medalogix, a clinical decision support company. Together, the two complementary companies create a leading healthcare technology platform that brings real efficiencies and improved patient care, starting with home-based healthcare and expanding across the broader healthcare industry. Berkshire is the majority owner of the combined company.
The team was led by partners John Harkrider and Craig Minerva along with associates Laviana Alharmoosh, Josh Jowdy, and Megan Dill. The deal closed on March 19, 2025.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Consumer Brands CPG Legal Forum 2026
Speaking Engagement
NBA CLS 39th Annual Corporate Counsel Conference
Sponsorship
Antitrust
New Frontiers of Antitrust – 16th Annual International Conference of Concurrences Review
Speaking Engagement
Antitrust
GCR Live Global: Navigating the Future of Antitrust 2026
Speaking Engagement
Antitrust
Why Should I Care About Property Controls?
Speaking Engagement
Antitrust
What’s the Score, Your Honor? Conversation With Judge Richard Boulware
Podcast
LCA Renaissance Symposium XIX 2025
Speaking Engagement
Antitrust
Stakeholders 25th Annual CYOC Career Development Conference
Sponsorship
Antitrust
Japan Competition Law Update
Axinn Viewpoints
Antitrust
California's Crackdown on Algorithmic Pricing
Axinn Viewpoints
Antitrust